Both in Surgical Instruments
Bioventus vs SpyGlass Pharma
Over the past year BVS returned +29.3% and SGP returned +32.2%; their daily moves had a correlation of 0.08.
BVS +29.3% SGP +32.2%Growth of $1, one year, split-adjusted
| Metric | BVS | SGP |
|---|---|---|
| Price | $11.01 | $34.89 |
| Market cap | $751.7M | $1.17B |
| Today | −16.31% | +3.72% |
| 1 month | −18.6% | +36.3% |
| 6 months | +3.0% | +42.9% |
| Year to date | +47.9% | — |
| 1 year | +68.0% | — |
| Revenue growth (YoY) | +2.7% | — |
| Gross margin | 68.2% | — |
| Net margin | 4.2% | — |
| P/E (TTM) | 12.5× | — |
| Price / sales | 1.3× | — |
| Net cash | -$199.1M | $234.2M |
| Dividend yield | — | — |
| Volatility (60d) | 55.1% | 46.8% |
| Short % of float | 6.9% | 20.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).